Evaluation of a Targeted Magnetic Resonance Imaging Contrast Agent in Prostate Cancer Patients
Clinical trial NCT06262139 · RECRUITING
Trial details
- NCT number
- NCT06262139
- Sponsor
- Songqi Gao
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-25
- Primary completion
- 2026-12-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.